Retrospective Foot and Ankle Data Collection

Sponsor
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05234801
Collaborator
(none)
300
1
4
74.8

Study Details

Study Description

Brief Summary

A retrospective post-market data collection study of the following implant devices :
  • DARCO™ Headed Cannulated Screw

  • ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System

  • ORTHOLOCTM 3Di 2 Foot Reconstruction System: CROSSCHECK™ Module

Condition or Disease Intervention/Treatment Phase
  • Device: DARCO™ Headed Cannulated Screw
  • Device: ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System
  • Device: ORTHOLOCTM 3Di 2 Foot Reconstruction System: CROSSCHECK™ Module

Detailed Description

A retrospective post-market data collection study designed to collect safety and performance Standard of Care data on patients who have undergone routine lower limb surgery that involved one of the following implant devices as per the indication for use:

  • DARCO™ Headed Cannulated Screw

  • ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System

  • ORTHOLOCTM 3Di 2 Foot Reconstruction System: CROSSCHECK™ Module

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
A Retrospective Data Collection Study of the Internal Fixation and Reconstruction of Bones in the Foot & Ankle Using Various Devices: DARCO Heads; CROSS CHECK 3Di; OrthoLoc 3Di
Actual Study Start Date :
Mar 30, 2022
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Jul 30, 2022

Arms and Interventions

Arm Intervention/Treatment
DARCO™ Headed Cannulated Screw

Patients who received a device from the DARCO™ Headed Cannulated Screw family of devices during routine lower limb surgery.

Device: DARCO™ Headed Cannulated Screw
The DARCO™ Headed Cannulated Screw is a multi-size screw system designed to be used over a guide pin or wire with instrumentation to provide interfragmentary compression and stability for bone fracture/fragment fixation.

ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System

Patients who received a device from the ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System family of devices during routine lower limb surgery.

Device: ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System
A multi-indication foot reconstruction solution providing indication specific implants and instruments designed to address the unique demands of the forefoot and midfoot.

ORTHOLOCTM 3Di 2 Foot Reconstruction System: CROSSCHECK™ Module

Patients who received a device from the ORTHOLOCTM 3Di 2 Foot Reconstruction System: CROSSCHECK™ Module family of devices during routine lower limb surgery.

Device: ORTHOLOCTM 3Di 2 Foot Reconstruction System: CROSSCHECK™ Module
A comprehensive fixation system consisting of a wide variety of plate options, created with the purpose of stabilization and fixation of fractures, revision procedures, joint fusion and reconstruction of small bones of the feet.

Outcome Measures

Primary Outcome Measures

  1. To demonstrate the performance of the devices concerned. [1 year.]

    Device related intra and post operative adverse events

  2. To demonstrate the safety of the devices concerned. [3 months]

    Device related intra and post operative adverse events

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Patients 18 years or older at the time of index procedure

• Patients who previously received:

  • the Charlotte™ MUC Screw System in accordance with the indications for use: for fixation of bone fractures or for bone reconstruction.

  • the CROSSCHECKTM in accordance with the indications for use: Stabilization of fresh fractures, revision procedures, joint fusion and reconstruction of small bones of the feet.

  • the ORTHOLOC™ 3Di Recon-Midfoot/Flatfoot System in accordance with the indications for use: Stabilization of fresh fractures, revision procedures, joint fusion and reconstruction of small bones of the feet.

  • a DARCO™ Headed Cannulated Screw in accordance with the indications for use: for bone fracture fixation and bone fragment fixation.

Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust Oswestry Shropshire United Kingdom SY10 7AG

Sponsors and Collaborators

  • Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust

Investigators

  • Study Chair: Andrew Bing, FRCS, Robert Jones and Agnes Hunt Orthopaedic Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
ClinicalTrials.gov Identifier:
NCT05234801
Other Study ID Numbers:
  • RL1 849
First Posted:
Feb 10, 2022
Last Update Posted:
May 24, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 24, 2022